Business Description
GE HealthCare Technologies Inc
NAICS : 325413
SIC : 3844
ISIN : BRGEHCBDR009
Share Class Description:
BSP:GEHC34: BRDRTotal Employee Number:
54,000Compare
Compare
Traded in other countries / regions
GEHC.USAGEHC.MexicoL0T.Germany1GEHC.ItalyGEHC34.Brazil IPO Date
2024-09-02Description
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 0.99 | |||||
Debt-to-EBITDA | 2.94 | |||||
Interest Coverage | 6.22 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.75 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.7 | |||||
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year EPS without NRI Growth Rate | -0.3 | |||||
3-Year FCF Growth Rate | -6.1 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.96 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.66 | |||||
9-Day RSI | 41.05 | |||||
14-Day RSI | 40.66 | |||||
3-1 Month Momentum % | -10.11 | |||||
6-1 Month Momentum % | -17.86 | |||||
12-1 Month Momentum % | -18.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.95 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 64.8 | |||||
Days Sales Outstanding | 60.46 | |||||
Days Payable | 90.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.17 | |||||
Forward Dividend Yield % | 0.22 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -1.86 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.15 | |||||
Operating Margin % | 12.63 | |||||
Net Margin % | 9.1 | |||||
EBITDA Margin % | 17.17 | |||||
FCF Margin % | 7.26 | |||||
OCF Margin % | 9.66 | |||||
ROE % | 19.12 | |||||
ROA % | 5.33 | |||||
ROIC % | 6.66 | |||||
3-Year ROIIC % | 2.85 | |||||
ROC (Joel Greenblatt) % | 100.21 | |||||
ROCE % | 11.41 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.75 | |||||
Forward PE Ratio | 1.55 | |||||
PE Ratio without NRI | 13.52 | |||||
PEG Ratio | 7.12 | |||||
PS Ratio | 1.34 | |||||
PB Ratio | 2.63 | |||||
Price-to-Free-Cash-Flow | 18.58 | |||||
Price-to-Operating-Cash-Flow | 13.92 | |||||
EV-to-EBIT | 12.17 | |||||
EV-to-Forward-EBIT | 11.29 | |||||
EV-to-EBITDA | 10.16 | |||||
EV-to-Forward-EBITDA | 9.57 | |||||
EV-to-Revenue | 1.74 | |||||
EV-to-Forward-Revenue | 1.67 | |||||
EV-to-FCF | 24.09 | |||||
Price-to-GF-Value | 0.72 | |||||
Earnings Yield (Greenblatt) % | 8.22 | |||||
FCF Yield % | 5.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GE HealthCare Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 113,269.204 | ||
| EPS (TTM) (R$) | 22.618 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 23.39 | ||
| 14-Day RSI | 40.66 | ||
| 14-Day ATR (R$) | 0.511037 | ||
| 20-Day SMA (R$) | 39.594 | ||
| 12-1 Month Momentum % | -18.33 | ||
| 52-Week Range (R$) | 38.64 - 60.61 | ||
| Shares Outstanding (Mil) | 454.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GE HealthCare Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GE HealthCare Technologies Inc Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 08:30 | In 106 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 105 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 08:30 | In 14 days | ||
| Second quarter earnings results for 2026 | 2026-07-29 | In 13 days | ||
| BRL 0.021138 Cash Dividend | 2026-07-23 | In 7 days | ||
| Jefferies Global Healthcare Conference | 2026-06-03 08:20 | 39.41 (-1.50%) | ||
| Guidance call for 2026 | 2026-05-12 13:40 | 39.13 (+0.00%) | ||
| General meeting for 2026 | 2026-05-07 08:00 | 45.70 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 08:30 | 45.70 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 45.70 (+0.00%) |
Show
Entries
GE HealthCare Technologies Inc Frequently Asked Questions
What is GE HealthCare Technologies Inc(BSP:GEHC34)'s stock price today?
The current price of BSP:GEHC34 is R$38.64. The 52 week high of BSP:GEHC34 is R$60.61 and 52 week low is R$38.64.
When is next earnings date of GE HealthCare Technologies Inc(BSP:GEHC34)?
The next earnings date of GE HealthCare Technologies Inc(BSP:GEHC34) is 2026-07-29.
Does GE HealthCare Technologies Inc(BSP:GEHC34) pay dividends? If so, how much?
The Dividend Yield %  of GE HealthCare Technologies Inc(BSP:GEHC34) is 0.17% (As of Today), Highest Dividend Payout Ratio of GE HealthCare Technologies Inc(BSP:GEHC34) was 0.03. The lowest was 0.02. And the median was 0.03. The  Forward Dividend Yield % of GE HealthCare Technologies Inc(BSP:GEHC34) is 0.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on GE HealthCare Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers